Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Countries

 

Genetics: the M&A drive

The big diagnostic lab groups are on a frantic M&A drive to capture capacity in genetic testing. The deals reflect the hunger for specialist genetic doctors, biologists and counsellors in a manpower intensive field which is seeing explosive growth. We look at recent deals and name the new competitors who are entering the market.
January 13, 2022

Intermedica and Hapvida’s get green light for merger

Two giants of Brazilian healthcare, listed HMOs Hapvida Participacoes e Investimentos SA and Grupo Notre Dame Intermedica Participacoes (GNDI), have received approval to merge from the country's antitrust authority CADE. The merger will create the country's biggest provider of health insurance policies, with around a 20% share of the for-profit market by number of users, and a 10% share of revenue.
January 13, 2022

Ramsay share price slumps after elective surgery ban in Australia

International hospital operator Ramsay’s share price fell 5.7% last Thursday, following the announcement that the Australian state of Victoria was reintroducing restrictions on non-urgent elective surgeries. On Friday, New South Wales followed suit.
January 13, 2022

Dutch competition authority blocks two acquisitions

The Dutch Authority for Consumers and Markets (ACM) has blocked two major healthcare acquisitions, marking what some observers believe is a new level of proactiveness for the antitrust body.
January 13, 2022

Greek consolidation ramps up ahead of Ethniki decision

The Greek health care services sector continues to consolidate as rivals face up to near certainty that CVC, which owns the largest hospital group in Greece, Hellenic Healthcare Group, will finally get the green flag for its acquisition of Ethniki Insurance. That would create a dominant payor/provider. So how does that affect number two hospital player Athens Medical and Bioatriki, the largest lab network?
January 13, 2022

IHH to “vigorously defend” $6.5bn lawsuit

Listed Malaysian hospital group IHH Healthcare says it will 'vigorously defend' a $6.5bn suit by US fund Emqore relating to the issuance of shares by IHH-owned Indian hospital group Fortis.
January 13, 2022
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us